These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2808196)

  • 1. A prospective study of ofloxacin in acute exacerbations of chronic respiratory disease associated with Pseudomonas aeruginosa.
    Meek JC; Maesen FP; Davies BI
    J Antimicrob Chemother; 1989 Sep; 24(3):447-53. PubMed ID: 2808196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease.
    Maesen FP; Davies BI; Baur C; Sumajow CA
    J Antimicrob Chemother; 1986 Nov; 18(5):629-34. PubMed ID: 3468098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.
    Eron LJ; Gentry LO
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):435-9. PubMed ID: 1643820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparative study of ofloxacin (Hoe 280) and trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbations of chronic bronchitis and chronic obstructive lung disease.
    Boye NP; Gaustad P
    Infection; 1991; 19 Suppl 7():S388-90. PubMed ID: 1804789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin treatment of difficult infections of the skin and skin structure.
    Gentry LO; Rodriguez-Gomez G
    Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Jensen T; Pedersen SS; Nielsen CH; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Oct; 20(4):585-94. PubMed ID: 3479420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation.
    Brook I; Ledney GD
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1387-9. PubMed ID: 2117418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary Pseudomonas infections].
    Yu GH; Yuan JP; Zhong NS
    Zhonghua Nei Ke Za Zhi; 1990 Feb; 29(2):94-7, 126. PubMed ID: 2209236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():1-8. PubMed ID: 6352611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory infections: clinical experiences with the new quinolones.
    Davies BI; Maesen FP
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S53-7. PubMed ID: 3438151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
    Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
    Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic efficacy of ofloxacin against experimental pneumonia with Pseudomonas aeruginosa in guinea pigs.
    Otani T; Nakajima R; Hashimoto S; Iigo Y; Ishida Y; Une T; Osada Y
    Arzneimittelforschung; 1989 Jun; 39(6):694-7. PubMed ID: 2775337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections].
    Nakamori Y; Tsuboi E; Narui K; Nakatani T; Nakata K; Sugi H
    Jpn J Antibiot; 1992 May; 45(5):539-47. PubMed ID: 1512940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.
    Taylor RF; Hodson ME; Pitt TL
    Thorax; 1993 Oct; 48(10):1002-5. PubMed ID: 8256228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa.
    Geller DE; Flume PA; Staab D; Fischer R; Loutit JS; Conrad DJ;
    Am J Respir Crit Care Med; 2011 Jun; 183(11):1510-6. PubMed ID: 21471106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temafloxacin in acute purulent exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; Gubbelmans HL; Cremers HM
    J Antimicrob Chemother; 1990 Aug; 26(2):237-46. PubMed ID: 2120178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ofloxacin therapy for invasive external otitis.
    Zikk D; Rapoport Y; Redianu C; Shalit I; Himmelfarb MZ
    Ann Otol Rhinol Laryngol; 1991 Aug; 100(8):632-7. PubMed ID: 1908200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease.
    Watanabe A
    Infection; 1991; 19 Suppl 7():S384-7. PubMed ID: 1804788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
    BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.